Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05304390 · ClinicalTrials.gov registry record · NA
A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of Seattle
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT05304390 is a NA study that was terminated before completion, run by Fred Hutchinson Cancer Center. The registered enrollment target is 53 participants.
The verdict
NCT05304390, a NA study, was terminated before completion, sponsored by Fred Hutchinson Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
This clinical trial develops a tailored screening and smoking cessation program for the lesbian, gay, bisexual, transgender (trans) and queer (LGBTQ) community of Seattle, Washington. A lung cancer screening program may help LGTBQ people who smoke overcome unique barriers that keep them from receiving preventive care, and constantly facing healthcare discrimination. Members of the LGBTQ community have historically smoked at higher rates than the general population and thus could benefit greatly from targeted efforts to improve lung cancer screening and smoking cessation implementation.
Interventions
- BEHAVIORAL Smoking Cessation Intervention
- OTHER Questionnaire Administration
- BEHAVIORAL Patient Navigation
- PROCEDURE Carbon Monoxide Measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2022-06-06 |
| Est. Completion | 2024-10-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05304390
The ClinicalTrials.gov registry entry for NCT05304390 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Smoking Cessation Intervention is the first listed.
NCT05304390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05304390 about?
NCT05304390 is a clinical study titled "A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of Seattle". This clinical trial develops a tailored screening and smoking cessation program for the lesbian, gay, bisexual, transgender (trans) and queer (LGBTQ) community of Seattle, Washington. A lung cancer screening program may help LGTBQ people who smoke overcome unique barriers that keep them from receivi...
What is the current status of trial NCT05304390?
This trial is currently terminated. It is a NA study. The enrollment target is 53 participants. The study started on 2022-06-06. Estimated completion is 2024-10-28.
What interventions are being tested in trial NCT05304390?
The interventions under investigation include: Smoking Cessation Intervention (BEHAVIORAL), Questionnaire Administration (OTHER), Patient Navigation (BEHAVIORAL), Carbon Monoxide Measurement (PROCEDURE).
Who is sponsoring clinical trial NCT05304390?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.